A Randomised, Controlled, Assessor-blind, Parallel Groups, Multi-national, Multi-centre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Women Undergoing an ART Programme
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2018
At a glance
- Drugs Follitropin delta (Primary) ; Follitropin alfa
- Indications Infertility
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Feb 2012 Planned number of patients changed from 300 to 330 as reported by European Clinical Trials Database record.